Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Hill-Rom Holdings Acquires Welch Allyn

By HospiMedica International staff writers
Posted on 29 Jun 2015
Hill-Rom Holdings (Batesville, IN, USA), a leading provider of technologies and services to the healthcare industry, has agreed to purchase Welch Allyn (Skaneateles Falls, NY, USA) in a bid to expand into the point-of-care diagnostics market.

The mutual infrastructure-leveraging move, part of a larger merger process that is transforming the healthcare technology industry, will allow for improved offerings in areas such as diagnostics, sensing and patient-monitoring technologies, clinical workflow, surgical safety and efficiency, respiratory health, wound care and prevention, and mobility technology. More...
The integrated company will thus hold positions across the total care continuum, including primary and intensive care units (ICUs), patient rooms, operating rooms (ORs), and post-acute care wards.

The combined entity will also expand its channel access and call points, as well as enhance clinical workflow through electronic medical record (EMR) connectivity solutions. In a joint statement, the companies said that combining Hill-Rom’s leading position in hospitals and ORs worldwide with Welch Allyn’s leading position in point of care diagnostics and testing would expand their ability to help healthcare providers focus on patient care solutions, and provide a wide range of innovative solutions to a global patient-centric, customer base focused on quality and efficiency.

“As one company, we will have the infrastructure, capabilities and innovative product portfolio to faster pursue a differentiated business model that meets the evolving needs of patients and customers and delivers superior healthcare outcomes across multiple care settings,” said John Greisch, president and CEO of Hill-Rom. “We look forward to welcoming the Welch Allyn team to Hill-Rom and combining our two great companies to continue our shared mission of improving patient outcomes and reducing patient costs.”

“This transaction represents a compelling opportunity for Welch Allyn with the right partner in Hill-Rom, who appreciates our company's special history, strengths, and strategy,” said Steve Meyer, president and CEO of Welch Allyn. “Hill-Rom and Welch Allyn share a commitment to patients and a history of delivering innovative solutions. Hill-Rom has the scale, geographic reach, experience and vision necessary to foster the next stage of growth and to ensure Welch Allyn's continued success.”

The acquisition was made for approximately USD 2.05 billion in cash and stock. Under the terms of the agreement, Welch Allyn shareholders will receive USD 1.625 billion in cash and approximately 8.1 million newly-issued shares of Hill-Rom common stock.

Related Links:

Hill-Rom Holdings
Welch Allyn



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Spirometry & Oximetry Software
MIR Spiro
Isolation Stretcher
IS 736
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.